ES2177531T3 - Receptor de lipoproteinas de baja densidad (ldl), su produccion y su utilizacion. - Google Patents

Receptor de lipoproteinas de baja densidad (ldl), su produccion y su utilizacion.

Info

Publication number
ES2177531T3
ES2177531T3 ES93100587T ES93100587T ES2177531T3 ES 2177531 T3 ES2177531 T3 ES 2177531T3 ES 93100587 T ES93100587 T ES 93100587T ES 93100587 T ES93100587 T ES 93100587T ES 2177531 T3 ES2177531 T3 ES 2177531T3
Authority
ES
Spain
Prior art keywords
ldl
production
low density
density lipoprotein
lipoprotein receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93100587T
Other languages
English (en)
Inventor
Menachem Rubinstein
Daniela Novick
Nathan Tal
Dina G Fischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yeda Research and Development Co Ltd
Original Assignee
Yeda Research and Development Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL100696A external-priority patent/IL100696A0/xx
Application filed by Yeda Research and Development Co Ltd filed Critical Yeda Research and Development Co Ltd
Application granted granted Critical
Publication of ES2177531T3 publication Critical patent/ES2177531T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Sewing Machines And Sewing (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)

Abstract

SE DESCRIBE UN RECEPTOR PROTEINA LDL SOLUBLE. PUEDE SER AISLADO A PARTIR DE CELULAS QUE HAN SIDO TRATADAS CON UN INTERFERON, O PRODUCIDAS MEDIANTE TECNICAS RECOMBINANTES. EL RECEPTOR PROTEINA LDL SOLUBLE ES UTILIZABLE EN LA PROTECCION DE MAMIFEROS CONTRA INFECCIONES VIRALES.
ES93100587T 1992-01-19 1993-01-15 Receptor de lipoproteinas de baja densidad (ldl), su produccion y su utilizacion. Expired - Lifetime ES2177531T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IL100696A IL100696A0 (en) 1992-01-19 1992-01-19 Antiviral protein and its preparation
IL10291592A IL102915A (en) 1992-01-19 1992-08-23 Soluble ldl receptor and its preparation

Publications (1)

Publication Number Publication Date
ES2177531T3 true ES2177531T3 (es) 2002-12-16

Family

ID=26322379

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93100587T Expired - Lifetime ES2177531T3 (es) 1992-01-19 1993-01-15 Receptor de lipoproteinas de baja densidad (ldl), su produccion y su utilizacion.

Country Status (10)

Country Link
EP (1) EP0553667B1 (es)
JP (2) JP3784078B2 (es)
AT (1) ATE218361T1 (es)
AU (1) AU663751B2 (es)
CA (1) CA2087494C (es)
DE (1) DE69331977T2 (es)
DK (1) DK0553667T3 (es)
ES (1) ES2177531T3 (es)
IL (1) IL102915A (es)
PT (1) PT553667E (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2069799A (en) * 1998-01-29 1999-08-16 Patrick Thomas Prendergast Therapeutic administration of low density lipoprotein receptor for viral infections and immune regulation
CN107011445B (zh) 2007-06-01 2021-06-29 马里兰大学巴尔的摩分校 免疫球蛋白恒定区Fc受体结合剂
IL188628A0 (en) * 2008-01-07 2008-12-29 Yeda Res & Dev Use of soluble ldl-r for viral hepatitis
DK2598533T3 (en) 2010-07-28 2019-04-23 Gliknik Inc Fusion proteins of natural human protein fragments to create in an orderly fashion multimerized immunoglobulin FC compositions
CA2899433A1 (en) * 2012-01-27 2013-08-01 Gliknik Inc. Fusion proteins comprising igg2 hinge domains
EP3464347B1 (en) 2016-06-07 2023-05-31 Gliknik Inc. Cysteine-optimized stradomers
CN110177802A (zh) 2016-12-09 2019-08-27 格利克尼克股份有限公司 多聚化stradomer GL-2045的制造优化
WO2024057315A1 (en) * 2022-09-15 2024-03-21 Yeda Research And Development Co. Ltd. Compositions and methods for virotherapy
WO2024121798A1 (en) * 2022-12-08 2024-06-13 Csl Behring Llc Dissociable envelope binding proteins and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4614651A (en) * 1981-07-12 1986-09-30 Damon Biotech, Inc. Interferon epsilon
US4454115A (en) * 1981-10-23 1984-06-12 Wisconsin Alumni Research Foundation Method of reducing the level of low density lipoproteins in the serum of a patient
CA2055122A1 (en) * 1990-11-13 1992-05-14 Robert I. Grove Methods for stimulating ldl uptake and ldl receptor expression

Also Published As

Publication number Publication date
JP4326534B2 (ja) 2009-09-09
JP2006136341A (ja) 2006-06-01
DK0553667T3 (da) 2002-09-16
JPH06220099A (ja) 1994-08-09
IL102915A (en) 2005-12-18
ATE218361T1 (de) 2002-06-15
JP3784078B2 (ja) 2006-06-07
CA2087494C (en) 2008-10-07
EP0553667B1 (en) 2002-06-05
AU3188993A (en) 1993-07-22
DE69331977D1 (de) 2002-07-11
AU663751B2 (en) 1995-10-19
DE69331977T2 (de) 2002-09-19
EP0553667A1 (en) 1993-08-04
IL102915A0 (en) 1993-01-31
CA2087494A1 (en) 1993-07-20
PT553667E (pt) 2002-10-31

Similar Documents

Publication Publication Date Title
MX9205710A (es) Separaciones acrecentadas de gas en membrana
EP1304335A3 (en) Hepatitis C virus protease
FI935808A (fi) Hepatit-C-virus (HCV) polypeptider
PT95093A (pt) Metodos para a culturizacao de hvc em celulas eucarioticas
ES2177531T3 (es) Receptor de lipoproteinas de baja densidad (ldl), su produccion y su utilizacion.
DE69106562D1 (de) Oberfläche mit verringerter Proteinwechselwirkung.
MX9304209A (es) Composicion y metodo de tratamiento de hepatitis b.
ITRM930179A0 (it) Apparecchio e procedimento per il riconoscimento di caratteri manoscritti.
DE59406462D1 (de) Einrichtung zur verhinderung von unterwasserwirbeln an pumpeneinläufen
DE69320548D1 (de) Vorrichtung zum Halten von Kontaktlinsen
IT8221463A0 (it) Perfezionata disposizione atta ad esaltare il soffio e/o l'estinzione d'arco tra i contatti d'interruttori o simili.
DE60026666D1 (de) Induktion von antigen-spezifischen T-Zellen durch Interferon
DE59104376D1 (de) Montageelement.
GR1002180B (en) Method for preventing the reproduction of virus in mammals cells by using protein conjugates of a monoclonic antibody antivirus
DE59209310D1 (de) Impfstoffe auf Basis geänderter Boviner Herpesviren Typ 1
EP0380995A3 (de) Tischsystem
ATE127493T1 (de) Oligophosphate mit antiviraler wirkung.
ATA225394A (de) Verbesserungen am photographischen system zur erzeugung von abbildungen von makroobjekten
DE69416453D1 (de) HCV-Peptide und deren Verwendung
ITTO930742A1 (it) Tavolo con piano oscillante e carrello retrattile.
IT9064318V0 (it) Braciere in lamiera con paravento ed alloggiamenti per i supporti di appoggio laterali ricvati dal suo corpo e con protezione comandi da piano di appoggio
IT8921373A0 (it) Arco per il lancio di frecce e simili.
GB9315259D0 (en) Recombinant viruses
BR7300981U (pt) Mesa vibratória signorelli
FI921778A0 (fi) Fog mellan betongpelare och fundament eller foerlaengningsfog i pelare.